Table 2. Sensitivity analyses for initial rSO2 and mean rSO2.
Outcomes | Excluding study | WMD and 95% CI | P-value | Heterogeneity (%) | P-value for heterogeneity |
---|---|---|---|---|---|
Initial rSO2 (%) | Ahn 2013 | 10.77 (6.02 to 15.52) | <0.001 | 74.0 | 0.002 |
Genbrugge 2015 | 10.30 (5.44 to 15.16) | <0.001 | 76.1 | 0.001 | |
Fukuda 2014 | 10.27 (5.29 to 15.25) | <0.001 | 75.9 | 0.001 | |
Koyama 2013 | 9.91 (4.66 to 15.16) | <0.001 | 76.4 | 0.001 | |
Meex 2013 | 10.36 (5.75 to 14.97) | <0.001 | 76.1 | 0.001 | |
Ibrahim 2015 | 8.43 (5.96 to 10.90) | <0.001 | 0.0 | 0.961 | |
Prosen 2018 | 10.44 (5.24 to 15.64) | <0.001 | 64.9 | 0.014 | |
Mean rSO2 (%) | Ahn 2013 | 14.02 (10.00 to 18.04) | <0.001 | 78.2 | <0.001 |
Parnia 2014 | 13.38 (9.70 to 17.06) | <0.001 | 75.7 | <0.001 | |
Genbrugge 2015 | 14.65 (10.53 to 18.77) | <0.001 | 76.1 | <0.001 | |
Singer 2014 | 14.79 (10.85 to 18.73) | <0.001 | 75.7 | <0.001 | |
Parnia 2012 | 13.94 (10.06 to 17.82) | <0.001 | 78.1 | <0.001 | |
Schewe 2014 | 14.40 (10.68 to 18.13) | <0.001 | 77.9 | <0.001 | |
Ibrahim 2015 | 12.31 (9.83 to 14.78) | <0.001 | 31.4 | 0.167 | |
Parnia 2016 | 14.68 (10.56 to 18.79) | <0.001 | 75.2 | <0.001 | |
Prosen 2018 | 13.98 (10.06 to 17.91) | <0.001 | 78.2 | <0.001 | |
Singer 2018 | 14.79 (10.87 to 18.71) | <0.001 | 75.9 | <0.001 |
*rSO2: regional cerebral oxygen saturation; WMD: weighted mean difference.